Comparative analysis of methotrexate polyglutamates in lymphoblast preparations from bone marrow and blood, and the contribution of residual red blood cells

Journal of Cancer Research and Clinical Oncology

Volumn 126, Issue 7, 2000, Pages 407-411

  Weigand, M ^a   Frei, E ^a   Wiessler, M ^a   Graf, N ^b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

Acute lymphoblastic leukemia; Lymphoblast preparation; Methotrexate polyglutamates; Red blood cells

Indexed keywords

METHOTREXATE POLYGLUTAMATE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; BONE MARROW CELL; CHILD; CLINICAL ARTICLE; DRUG DISTRIBUTION; DRUG METABOLISM; ERYTHROCYTE; FEMALE; HUMAN; HUMAN CELL; LYMPHOBLAST; MALE; PRIORITY JOURNAL;

EID: 0033937868     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00008489     Document Type: Article

References (14)

1. Bertino JR, Göker E, Gorlick R, Li WW, Banerjee D (1996) Resistance mechanisms to methotrexate in tumors. Stem Cells 14: 5-9
2. Buchholz B, Frei E, Eisenbarth J, Weigand M, Ludwig R (1996) Time course of methotrexate polyglutamate formation and degradation in the preB-leukemia cell line Nalmo6 and in lymphoblasts from children with leukemia. Eur J Cancer 32: 2101-2107
3. Costa M da, Iqbal M (1981) The transport and accumulation of methotrexate in human erythrocytes. Cancer (11): 2427-2432
4. Göker E, Lin JT, Trippett T, Elisseyeff Y, Tong WP, Niedzwiecki D, Tan C, Steinherz P, Schweitzer BI, Bertino J (1993) Decreased polyglutamylation of methotrexate in acute lymphoblastic leukemia blasts in adults compared to children with this disease. Leukemia 7: 1000-1004
5. Göker E, Kheradpour A, Waltham M, Banerjee D, Tong WP, Elisseyeff Y, Bertino JR (1995) Acute monocytic leukemia: a myeloid leukemia subset that may be sensitive to methotrexate. Leukemia 9: 274-276
6. Lena N, Imbert AM, Brunet P, Cano JP, Carcassonne Y (1987) Kinetics of methotrexate and its metabolites in red blood cells. Cancer Drug Deliv 4: 119-127
7. Lin JT, Tong WP, Trippett TM, Niedzwiecki D, Tao Y, Tan C, Steinherz P, Schweitzer BI (1991) Basis for natural resistance in human acute non-lymphocytic leukemia. Leukemia Res 15: 1191-1196
8. Masson E, Relling M, Synold TW, Liu Q, Schuetz JD, Sandlund JT, Pui CH (1996) Accumulation of methotrexate polyglutamates in lymphoblasts is a determinant of antileukemic effects in vivo. J Clin Invest 97: 73-80
9. Schrøder H (1990) In vivo methotrexate kinetics and metabolism in human hematopoetic cells. Danish Med Bull 37: 22-40
10. Synold TW, Relling MV, Boyett JM (1994) Blast cell methotrexate-polyglutamate accumulation in vivo differs by lineage, ploidy and methotrexate dose in acute lymphoblastic leukemia. J Clin Invest 94: 1996-2001
11. Trippett T, Schlemmer S, Elisseyeff Y, Göker E, Wachter M, Steinherz P, Tan C, Berman E, Wright JE, Rosowsky A, Schweitzer BI, Bertino JR (1992) Defective transport as a mechanism of acquired resistance to methotrexate in patients with acute lymphoblastic leukemia. Blood 80: 1158-1162
12. Weigand M, Frei E, Graf N, Buchholz B, Wolfrom C, Breuer A, Wiessler M (1999) Mechanisms of resistance to methotrexate in childhood acute lymphoblastic leukemia: circumvention of thymidylate synthase inhibition. J Cancer Res Clin Oncol 125: 513-519
13. Whitehead VM, Rosenblatt DS, Vuchich M-J, Shuster JJ, Witte A, Beaulieu D (1990) Accumulation of methotrexate polyglutamates in lymphoblasts at diagnosis of childhood acute lymphoblastic leukemia, a pilot prognostic factor analysis. Blood 76: 44-49
14. Whitehead VM, Rosenblatt DS, Vuchich M-J, Lauer SJ (1992) Accumulation of high levels of methotrexate polyglutamates in lymphoblasts from children with hyperdiploid (>50 chromosones) B-lineage acute lymphoblastic leukemia, a pediatric oncology group study. Blood 80: 1316-1323